FALAGARIO, UGO GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 3.586
EU - Europa 2.543
AS - Asia 2.377
SA - Sud America 487
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 9.079
Nazione #
US - Stati Uniti d'America 3.468
SG - Singapore 1.141
RU - Federazione Russa 659
IE - Irlanda 457
CN - Cina 424
BR - Brasile 386
IT - Italia 371
HK - Hong Kong 301
SE - Svezia 286
DE - Germania 186
FR - Francia 178
VN - Vietnam 166
BD - Bangladesh 94
GB - Regno Unito 81
IN - India 74
FI - Finlandia 71
UA - Ucraina 70
CA - Canada 53
MX - Messico 39
AT - Austria 36
AR - Argentina 29
IQ - Iraq 26
PL - Polonia 25
TR - Turchia 25
CZ - Repubblica Ceca 23
ZA - Sudafrica 23
VE - Venezuela 22
NL - Olanda 21
JP - Giappone 17
GR - Grecia 12
ES - Italia 11
ID - Indonesia 11
MA - Marocco 11
PE - Perù 10
PY - Paraguay 10
SA - Arabia Saudita 10
CO - Colombia 9
BE - Belgio 8
IR - Iran 8
CL - Cile 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
LT - Lituania 7
NP - Nepal 7
PK - Pakistan 7
AL - Albania 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
EC - Ecuador 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
IL - Israele 5
KG - Kirghizistan 5
LB - Libano 5
PH - Filippine 5
UZ - Uzbekistan 5
AU - Australia 4
CH - Svizzera 4
JO - Giordania 4
MY - Malesia 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CG - Congo 3
DK - Danimarca 3
HU - Ungheria 3
JM - Giamaica 3
KH - Cambogia 3
NO - Norvegia 3
PA - Panama 3
PS - Palestinian Territory 3
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
KW - Kuwait 2
KZ - Kazakistan 2
MD - Moldavia 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CU - Cuba 1
GY - Guiana 1
Totale 9.067
Città #
San Jose 1.043
Singapore 568
Dallas 506
Dublin 454
Ashburn 302
Hong Kong 299
Chandler 240
Nyköping 184
Beijing 166
Santa Clara 166
New York 153
Lauterbourg 119
Munich 81
Moscow 61
Los Angeles 52
Helsinki 50
Ho Chi Minh City 48
Rome 45
São Paulo 43
Princeton 42
Jacksonville 39
Hanoi 31
Milan 29
London 28
The Dalles 28
Bari 26
Frankfurt am Main 26
Nuremberg 26
Council Bluffs 25
Pune 25
Dearborn 21
Turku 20
Düsseldorf 19
Wilmington 19
Brooklyn 17
Orem 17
Vienna 16
Warsaw 16
Atlanta 15
Falkenstein 15
Toronto 15
Baghdad 14
Chennai 14
Guangzhou 13
Montreal 13
Olomouc 13
Seattle 13
Assago 12
Belo Horizonte 12
Boardman 12
Des Moines 12
Nanjing 12
San Francisco 12
Shanghai 12
Chicago 11
Da Nang 11
Johannesburg 11
Mexico City 11
Rio de Janeiro 11
Tokyo 11
Boston 10
Brno 10
Buffalo 10
Naples 10
Ottawa 10
Wuhan 10
Genoa 9
Haiphong 9
Paris 9
Phoenix 9
Hillsboro 8
Manchester 8
Brussels 7
Guarulhos 7
Houston 7
Marousi 7
Pescara 7
Bologna 6
Dhaka 6
Jiaxing 6
Porto Alegre 6
San José 6
Stockholm 6
Tehran 6
Washington 6
Bishkek 5
Biên Hòa 5
Brasília 5
Cape Town 5
Chengdu 5
Foggia 5
Miami 5
Amman 4
Ankara 4
Asunción 4
Buenos Aires 4
Campinas 4
Caracas 4
Ciudad del Este 4
Curitiba 4
Totale 5.587
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 222
Evaluation of citrate-based nutraceutical combinations and their impact on chemolysis in the management of urinary diversion device: a randomised double-blind placebo-controlled study on improved quality of life and clinical outcomes 194
Artificial intelligence and radiomics applications in adrenal lesions: a systematic review 182
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 169
Elderly patients and prostate biopsy. How old is too old? 144
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 141
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 138
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 137
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 133
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 130
A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data 126
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 123
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 123
Techniques for Penile Augmentation Surgery: A Systematic Review of Surgical Outcomes, Complications, and Quality of Life 122
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis 113
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 112
Advanced ureteroscopic techniques for the management of kidney stones 111
A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques 110
Male esthetic genital surgery: recommendations and gaps to be filled 107
Defining Prostate Cancer at Favorable Intermediate Risk: the Potential Utility Of Magnetic Resonance Imaging And Genomic Tests 106
Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre series 104
Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center 103
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators 102
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 100
Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index 97
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 97
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 97
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 94
Prostate cancer biomarkers: a practical review based on different clinical scenarios 92
Circulating Tumor DNA: A New Research Frontier in Urological Oncology from Localized to Metastatic Disease 91
Sexual function recovery following open and robotic radical prostatectomy: results of an academic penile rehabilitation program 91
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 91
Elderly patients and prostate biopsy. How old is too old? 90
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  90
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study 89
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 85
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 85
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 84
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 82
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 81
Nomogram predicting 30-day mortality after nephrectomy in the contemporary era: Results from the SEER database 79
Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors 79
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 78
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 77
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 76
Impact of low-intensity extracorporeal shockwave therapy on vascular parameters and sexual function in patients with arteriogenic erectile dysfunction 74
Stapled W-shaped (Hautmann) Orthotopic Ileal Neobladder. Functional Results and Complications over a 13-year Period 72
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 71
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle? 70
Minimally invasive surgical therapies (MISTs) for lower urinary tract symptoms (LUTS): promise or panacea? 70
ZSI-375 artificial urinary sphincter: efficacy, safety, and long-term outcomes 69
Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion 69
Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy 69
Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study 67
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer 66
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere? 66
A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer 65
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care 65
Penoscrotal approach for inflatable penile prosthesis implant: why it should be preferred 64
Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies 64
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 63
HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role 63
The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy 62
The natural history of untreated muscle-invasive bladder cancer 62
Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and Association with Molecular Subtypes-Preliminary Report 62
The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy 62
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 61
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression 61
Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” 60
Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy 59
Performance of prostate multiparametric Mri for prediction of prostate cancer extra-prostatic extension according to nccn risk categories: implication for surgical planning 59
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years' Report from the EAU Robotic Urology Section Scientific Working Group 59
Mini invasive approaches in the treatment of small renal masses: TC-guided renal cryoablation in elderly 58
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 58
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy 57
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 56
Radiomics in prostate cancer: an up-to-date review 56
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working Group 55
Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion 55
Refining Active Surveillance Eligibility in Intermediate-risk Non-muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence 54
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification 54
An original surgical approach to manage complete rectal lumen obliteration following stapled hemorrhoidopexy 54
External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted Biopsy 54
A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection 53
Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization 53
UroLift to preserve seminal parameters in young male with LUTS from BPH 52
Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer 52
Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in Males 52
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program 50
When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level 50
Decipher Score predicts prostate specific antigen persistence after prostatectomy 50
Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer 49
The Role of miRNA in the Management of Localized and Advanced Renal Masses, a Narrative Review of the Literature 49
Acute kidney injury as a predictor of infectious complications after mini-PCNL 49
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences 48
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 48
Robotic-assisted surgery for the treatment of urologic cancers: recent advances 47
Segmental Ureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis of Comparative Studies 46
Does race impact functional outcomes in patients undergoing robotic partial nephrectomy? 46
Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials) 46
Totale 8.182
Categoria #
all - tutte 57.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022319 13 13 10 11 33 7 26 11 56 62 6 71
2022/20231.211 116 86 37 62 72 97 8 98 534 34 41 26
2023/2024669 40 34 26 13 28 184 133 33 39 37 22 80
2024/20252.160 150 28 59 44 62 238 224 126 592 172 203 262
2025/20264.911 286 500 603 420 289 208 918 491 310 422 223 241
Totale 9.552